Rubin Bressler, Michael D. Katz
McGraw-Hill, Jan 1, 1993 - Medical - 689 pages
This book reviews the pharmacokinetic and pharmacodynamic changes of the elderly along with the potential adverse drug reactions to consider, providing guidelines on how these factors affect therapeutic decision making.
What people are saying - Write a review
We haven't found any reviews in the usual places.
absorption acid activity acute administration adverse effects agents agonists amiodarone anticholinergic antidepressants antihypertensive antipsychotic antipsychotic drugs anxiety arrhythmias associated asthma benzodiazepines beta blockers blood pressure bone calcium cancer carbamazepine cardiac cause chronic cimetidine Clin Pharmacol Ther clinical compliance corticosteroids creatinine daily decreased depression diabetes digoxin disease disopyramide disorder diuretics dopamine dosage dose drug interactions drug therapy dysfunction dyskinesia efficacy elderly patients elimination enzyme estrogen excreted flecainide gastrointestinal geriatric half-life headache hepatic hypertension hypotension impotence increased infections inhaled inhibition insulin intake intravenous levels levodopa lidocaine liver medications metabolism metabolites methotrexate mexiletine mg/day monitoring NSAIDs nutritional occur oral osteoporosis pain percent of patients pharmacokinetics pharmacologic phenytoin placebo population procainamide propafenone protein Psychiatry quinidine reactions receptors reduced regimen renal function response result risk salicylates seizures serum concentrations side effects studies symptoms syndrome Table tardive dyskinesia theophylline therapeutic tocainide total body clearance toxicity treated treatment trial urine ventricular vitamin